The following trials provide information to treat various types of gastrointestinal diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
- collapse A multicenter, randomized, double-blind, safety and efficacy study of H 199/18 with amoxicillin plus clarithromycin compared to H 199/18 for the eradication of Helicobacter pylori in subjects with active duodenal ulcer or history of duodenal ulcer disease
- collapse A multicenter, randomized, double-blind, safety and efficacy study of H 199/18 with clarithromycin compared to H 199/18 for the eradication of Helicobacter pylori in subjects with active duodenal ulcer or history of duodenal ulcer disease.
- collapse A multicenter, randomized, double-blind, safety and efficacy study of H 199/18 with amoxicillin plus clarithromycin compared to H 199/18 with clarithromycin for the eradication of Helicobacter pylori in subjects with active duodenal ulcer or history of duodenal ulcer disease
- collapse An interaction study between H 199/18 b.i.d., amoxicillin b.i.d. and clarithromycin b.i.d. in healthy male and female subjects
- collapse An interaction study between H 199/18 and warfarin in warfarin-treated patients
- collapse A pharmacokinetic study of H 199/18 in elderly male and female subjects
- collapse An interaction study between H 199/18 and cisapride in healthy male and female subjects
- collapse A bioequivalence study with 40 mg H 199/18 comparing a new tablet formulation with a capsule formulation in healthy subjects
- collapse An interaction study between H 199/18, amoxicillin and clarithromycin in healthy male and female subjects
- collapse A bioequivalence study with 20 mg H 199/18 comparing a new tablet formulation with a capsule formulation in healthy subjects
